ISMPP: Former Merck CEO outlines three ways pharma companies can regain lost prestige

By David Woods (david.woods@rxcomms.com) While the Golden Age of the pharmaceutical industry is over, and its reputation similar to that of the tobacco and oil industries, there is hope at hand – according to former Merck CEO Roy Vagelos. In a keynote address to the third annual meeting of the International Society for Medical Publication…

HOC people: Alan Bakst

By David Woods (dwoods@rxcomms.com) “An opportunity and a challenge”. That’s what Alan Bakst found when he became Director of Health Economics and Outcomes Research at TAP pharmaceuticals in Chicago in August 2004. Up until then, TAP didn’t have a stable and fully staffed group in health outcomes, so the opportunity came in building the group.…